Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
652.00    12.00 (1.88%)
Bid:
644.00
Ask:
660.00
Spread: 16.00 (2.484%)
Market Cap: £219.22m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Acquisition & Placing

15 Sep 2006 07:00

Embargoed: 0700hrs, 15 September 2006 Avingtrans plc ("Avingtrans") Acquisition and Placing The Board of Avingtrans plc is pleased to announce the conditional acquisitionof B&D Patterns Limited ("B&D") for consideration of up to ‚£10.5 million, ofwhich ‚£6.583 million is payable in cash and ‚£417,000 will be satisfied by theissue of Avingtrans ordinary shares of 5 pence each ("Avingtrans Shares") oncompletion and the remainder subject to an earn-out calculated by reference toB&D's profit before tax for the years ended 31 May 2007 and 31 May 2008.B&D is a manufacturer and supplier of critical jet engine components to theaerospace industry. It specialises in precision engineered gas and fuelcarrying rigid pipe asemblies, which are required to be manufactured to thehighest quality levels using computer numerically controlled machining as wellas non-destructive testing and X-Ray procedures.B&D, which owns freehold properties which have been independently valued at ‚£3.1m, made a profit before tax of ‚£1 million on turnover of ‚£10.4 million inthe year to 31 December 2005. As at 31 December 2005, it had net assets of ‚£2.5million.In connection with the acquisition, Avingtrans has conditionally placed1,426,000 Avingtrans shares with an institutional investor at a price per shareof 125 pence, raising ‚£1.78 million (the "Placing Shares"). Further to this,170,000 Avingtrans shares will be subject to a Vendor Placing at the same priceraising a further ‚£212,500. Application has been made for the Placing Shares tobe admitted to AIM and admission is expected on 20 September 2006. The sharesto be issued will all rank pari passu with the Avingtrans' existing ordinaryshares. The remainder of the consideration will be funded through debt.Ken Baker, Chairman of Avingtrans, commented: "I am delighted to announce thisacquisition. B&D Patterns is a high quality precision engineering company witha proven track record. Its acquisition will enhance Avingtrans' existingactivities servicing the aerospace industry and it will, we believe, beearnings enhancing in the current financial year. The acquisition continuesAvingtrans' strategy of acquiring profitable precision engineering companies tosupport the Group's organic growth."For further information please contact:Ken Baker, ChairmanSteve Lawrence, Managing DirectorAvingtrans plcTel. 01159 499 020Ben Simons/Adam ReynoldsHansard CommunicationsTel. 020 7245 1100Nick LoveringBridgewellTel. 020 7003 3000ENDAVINGTRANS PLC
Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.